• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从不吸烟人群中的小细胞肺癌。

Small-cell lung cancer in never-smokers.

机构信息

Service of Neumology, University Hospital Complex of Vigo, Vigo, Spain.

Department of Medical Oncology, Hospital HM La Esperanza, Santiago de Compostela, Spain.

出版信息

ESMO Open. 2021 Apr;6(2):100059. doi: 10.1016/j.esmoop.2021.100059. Epub 2021 Feb 26.

DOI:10.1016/j.esmoop.2021.100059
PMID:33640828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7920829/
Abstract

BACKGROUND

Lung cancer is a public health problem worldwide. Small-cell lung cancer (SCLC) is the most aggressive histologic type, with a 5-year survival <10%. SCLC is closely associated with tobacco consumption and infrequent in never-smokers. We aim to describe SCLC characteristics in never-smokers recruited in a radon-prone area.

PATIENTS AND METHODS

We designed a multicentric case series where SCLC cases were recruited consecutively following histologic confirmation. Detailed information was obtained for indoor radon exposure, occupation and environmental tobacco smoke. We also collected different clinical characteristics such as extended or limited disease at diagnosis.

RESULTS

We recruited 32 never-smoking SCLC cases. Median age was 75 years and 87.5% were women; 47% had extended disease. Median radon concentration was 182 Bq/m. There were no statistically significant differences in residential radon concentration neither regarding age at diagnosis nor regarding sex. The most frequent symptoms were constitutional syndrome (23.1%) and coughing (23.1%). As much as 63% of cases had an Eastern Cooperative Oncology Group Study (ECOG) status of 0-2. The 1- and 2-year survival rates were 34.4% and 21.9%, respectively. The 2-year survival rate with a localized tumor was 26.7%, compared with 18.8% for extended disease.

CONCLUSIONS

These results show, for the first time, that indoor radon might not be associated with SCLC characteristics at diagnosis in never-smokers, and also confirms the low survival of this aggressive type of lung cancer also for never-smokers.

摘要

背景

肺癌是全球范围内的一个公共卫生问题。小细胞肺癌(SCLC)是最具侵袭性的组织学类型,5 年生存率<10%。SCLC 与烟草消费密切相关,在从不吸烟者中很少见。我们旨在描述在氡高发地区招募的从不吸烟者中的 SCLC 特征。

患者和方法

我们设计了一项多中心病例系列研究,其中 SCLC 病例是在组织学确认后连续招募的。详细信息包括室内氡暴露、职业和环境烟草烟雾。我们还收集了不同的临床特征,如诊断时的广泛或局限疾病。

结果

我们招募了 32 例从不吸烟的 SCLC 患者。中位年龄为 75 岁,87.5%为女性;47%为广泛疾病。中位氡浓度为 182 Bq/m。诊断时的年龄和性别与住宅氡浓度均无统计学差异。最常见的症状是全身综合征(23.1%)和咳嗽(23.1%)。多达 63%的病例 ECOG 状态为 0-2。1 年和 2 年生存率分别为 34.4%和 21.9%。局限性肿瘤的 2 年生存率为 26.7%,而广泛疾病的生存率为 18.8%。

结论

这些结果首次表明,室内氡可能与从不吸烟者的 SCLC 特征无关,也证实了这种侵袭性肺癌在从不吸烟者中的低生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd59/7920829/5417a22693e1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd59/7920829/5417a22693e1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd59/7920829/5417a22693e1/gr1.jpg

相似文献

1
Small-cell lung cancer in never-smokers.从不吸烟人群中的小细胞肺癌。
ESMO Open. 2021 Apr;6(2):100059. doi: 10.1016/j.esmoop.2021.100059. Epub 2021 Feb 26.
2
Small cell lung cancer in never-smokers.从不吸烟者中的小细胞肺癌。
Eur Respir J. 2016 Mar;47(3):947-53. doi: 10.1183/13993003.01524-2015. Epub 2015 Dec 23.
3
Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study.住宅氡气与小细胞肺癌。小细胞研究的最终结果。
Arch Bronconeumol. 2022 Jul;58(7):542-546. doi: 10.1016/j.arbres.2021.01.027. Epub 2021 Feb 13.
4
Occupation as a risk factor of small cell lung cancer.职业与小细胞肺癌的风险因素。
Sci Rep. 2023 Mar 23;13(1):4727. doi: 10.1038/s41598-023-31991-0.
5
Residential radon and small cell lung cancer. A systematic review.住宅氡气与小细胞肺癌。系统综述。
Cancer Lett. 2018 Jul 10;426:57-62. doi: 10.1016/j.canlet.2018.04.003. Epub 2018 Apr 11.
6
Small Cell Lung Cancer. Methodology and Preliminary Results of the SMALL CELL Study.小细胞肺癌。SMALL CELL 研究的方法学和初步结果。
Arch Bronconeumol. 2017 Dec;53(12):675-681. doi: 10.1016/j.arbres.2017.04.016. Epub 2017 Jun 15.
7
Lung cancer in never-smokers: a case-control study in a radon-prone area (Galicia, Spain).不吸烟人群中的肺癌:一个氡高发地区(西班牙加利西亚)的病例对照研究。
Eur Respir J. 2014 Oct;44(4):994-1001. doi: 10.1183/09031936.00017114. Epub 2014 Jul 17.
8
Residential radon and lung cancer among never-smokers in Sweden.瑞典非吸烟者中的室内氡与肺癌
Epidemiology. 2001 Jul;12(4):396-404. doi: 10.1097/00001648-200107000-00009.
9
Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study.非吸烟者肺癌生存率与住宅氡暴露:LCRINS 研究结果。
Cancer Lett. 2020 Sep 1;487:21-26. doi: 10.1016/j.canlet.2020.05.022. Epub 2020 May 24.
10
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018.2011-2018 年吸烟与小细胞肺癌患者特征和结局的相关性。
JAMA Netw Open. 2022 Mar 1;5(3):e224830. doi: 10.1001/jamanetworkopen.2022.4830.

引用本文的文献

1
Associations between four insulin resistance (IR) surrogates and the risk of small cell lung cancer (SCLC).四种胰岛素抵抗(IR)替代指标与小细胞肺癌(SCLC)风险之间的关联。
Sci Rep. 2025 Jul 9;15(1):24632. doi: 10.1038/s41598-025-09548-0.
2
The current and emerging immunotherapy paradigm in small-cell lung cancer.小细胞肺癌当前及新出现的免疫治疗模式
Nat Cancer. 2025 Jun 5. doi: 10.1038/s43018-025-00992-5.
3
Current and future therapies for small cell lung carcinoma.小细胞肺癌的当前及未来治疗方法
J Hematol Oncol. 2025 Apr 1;18(1):37. doi: 10.1186/s13045-025-01690-6.
4
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics.小细胞肺癌治疗的临床转化研究新进展
Cancers (Basel). 2025 Jan 14;17(2):255. doi: 10.3390/cancers17020255.
5
Lung cancer in never smokers (LCINS): development of a UK national research strategy.从不吸烟者的肺癌(LCINS):英国国家研究战略的制定
BJC Rep. 2023 Jul 20;1(1):21. doi: 10.1038/s44276-023-00006-w.
6
Assessment of exposure to secondhand tobacco smoke in Spain: A scoping review.西班牙二手烟草烟雾暴露评估:一项范围综述
Tob Induc Dis. 2024 Oct 11;22. doi: 10.18332/tid/192118. eCollection 2024.
7
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.单细胞和空间蛋白质组-转录组分析揭示了小细胞肺癌中与神经内分泌特征相关的免疫浸润异质性。
Cell Discov. 2024 Sep 4;10(1):93. doi: 10.1038/s41421-024-00703-x.
8
Lost at SCLC: a review of potential platinum sensitizers.小细胞肺癌治疗失败的原因分析:铂类增敏剂的研究进展。
Cancer Metastasis Rev. 2024 Dec;43(4):1573-1578. doi: 10.1007/s10555-024-10207-5. Epub 2024 Aug 23.
9
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.小细胞肺癌分子特征和治疗靶点的新进展。
Nat Rev Clin Oncol. 2024 Aug;21(8):610-627. doi: 10.1038/s41571-024-00914-x. Epub 2024 Jul 4.
10
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.小细胞肺癌全景中的分子和遗传进展:从同质性到多样性。
Int J Mol Sci. 2023 Dec 22;25(1):224. doi: 10.3390/ijms25010224.